Thiazole pyrazolopyrimidines as CRF1 receptor antagonists

Details for Australian Patent Application No. 2007297421 (hide)

Owner Eli Lilly and Company

Inventors Myers, Jason Kenneth; Takakuwa, Takako; Hembre, Erik James; Hamdouchi, Chafiq Hamdouchi; Toth, James Lee; Hipskind, Philip Arthur; Chen, Zhaogen

Agent Spruson & Ferguson

Pub. Number AU-B-2007297421

PCT Pub. Number WO2008/036579

Priority 60/826,264 20.09.06 US

Filing date 17 September 2007

Wipo publication date 27 March 2008

Acceptance publication date 8 March 2012

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/505 (2006.01) - Pyrimidines

A61P 25/22 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

A61P 25/30 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

23 April 2009 PCT application entered the National Phase

  PCT publication WO2008/036579 Priority application(s): WO2008/036579

8 March 2012 Application Accepted

  Published as AU-B-2007297421

5 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007297426-Interactive three dimensional gaming device with recessed chambers

2007297420-Orthopedic plate system